Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Intec Pharma Ltd (NASDAQ: NTEC).

Full DD Report for NTEC

You must become a subscriber to view this report.


Recent News from (NASDAQ: NTEC)

Today's Research Reports on Trending Tickers: Oragenics and Intec Pharma
NEW YORK, NY / ACCESSWIRE / December 3, 2018 / There was no news to explain the new high that Intec Pharma hit on Friday but Oragenics surged over 30% after announcing the publication of a research paper last week. The Market Edge Initiates Coverage on: Oragenics, Inc. https://market...
Source: ACCESSWIRE IA
Date: December, 03 2018 07:50
Intec Pharma to Participate in Upcoming November Investment Conferences
JERUSALEM , Nov. 6, 2018 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that Company management will participate at the following upcoming investment conferences in November.  H.C. Wainwright 2018 Annual Israel Conference Date: ...
Source: PR Newswire
Date: November, 06 2018 07:00
Today's Research Reports on Stocks to Watch: GW Pharmaceuticals and Intec Pharma
NEW YORK, NY / ACCESSWIRE / September 20, 2018 / GW Pharmaceuticals hit a brand new high yesterday after a report revealed that the FDA is planning to reclassify the company’s Epidiolex to be allowed for medicinal use. Shares of Intec Pharma also saw gains despite a catalyst. RDI In...
Source: ACCESSWIRE IA
Date: September, 20 2018 08:00
Intec Pharma to Participate at Upcoming Investment Conferences
JERUSALEM , Sept. 20, 2018 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that Company management will participate at the following upcoming investment conferences.  Oppenheimer 2018 Fall Summit - Focused on Specialty Pharma and Ra...
Source: PR Newswire
Date: September, 20 2018 07:00
Intec Pharma Reports Second Quarter 2018 Financial Results and Corporate Update
JERUSALEM , Aug. 15, 2018 /PRNewswire/ --   Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the three and six months ended June 30, 2018 and provides a corporate update.  Highlights of the second quarter 2018 and recent wee...
Source: PR Newswire
Date: August, 15 2018 07:30
Intec Pharma- Parkinson's, Insomnia and a Cannabidiol Platform
Over the past couple of decades our most profitable sector has been biotech stocks. We use a process that has been refined over the years. The analysis is complex and time consuming, but worth the effort, asserts small cap expert Bill Mathews , editor of The Cheap Investor . We evaluat...
Source: MoneyShow.com
Date: July, 17 2018 01:00
Biotech: Take It On The Run
A recent study from Cowen Research says that biotech investors shouldn’t count on sell-side analysts’ ratings of stocks in the sector. In fact, biotech investors should do the exact opposite of their recommendations, and buy when analysts say sell, and vice versa. According to ...
Source: SeekingAlpha
Date: July, 05 2018 07:30
Intec Pharma Appoints William Bradley Hayes to Board of Directors
JERUSALEM , June 29, 2018 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC) ("Intec" or "the Company") today announces the appointment of William Bradley Hayes (Brad) to the Company's Board of Directors.  Mr. Hayes was formerly Executive Vice President, Chief Financia...
Source: PR Newswire
Date: June, 29 2018 07:00
Intec Pharma: Is It Time To Go Bottom Fishing?
Shares of Intec Pharma ( NTEC ) rose by over 50% shortly after I suggested readers pull the trigger after the secondary offering last August- from there the stock lost all signs of strength and is currently 22% in the red and trading near all-time lows. Chart Figure 1: NTEC daily a...
Source: SeekingAlpha
Date: June, 21 2018 04:39

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-147.818.138.247.65499,828
2018-12-137.837.918.007.70278,802
2018-12-127.507.798.207.34776,926
2018-12-117.727.508.007.50211,002
2018-12-107.357.687.847.35575,273

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1498,164189,71851.7421Short
2018-12-1350,92292,40355.1086Short
2018-12-12112,028270,05641.4832Short
2018-12-1115,32369,10022.1751Cover
2018-12-1063,460247,77225.6123Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NTEC.


About Intec Pharma Ltd (NASDAQ: NTEC)

Logo for Intec Pharma Ltd (NASDAQ: NTEC)

Not available

 

Contact Information

     

     

    Current Share Structure

    • Market Cap: $152,924,831 - 05/18/2018
    • Authorized: 50,000,000 - 05/01/2018
    • Issue and Outstanding: 32,537,198 - 05/01/2018

     


    Recent Filings from (NASDAQ: NTEC)

    Securities offered to employees under employee benefit plans
    Filing Type: S-8Filing Source: edgar
    Filing Date: August, 27 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: August, 15 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: June, 29 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: June, 28 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: May, 31 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: May, 23 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: May, 18 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: May, 15 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: May, 15 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: May, 11 2018

     

     


    Daily Technical Chart for (NASDAQ: NTEC)

    Daily Technical Chart for (NASDAQ: NTEC)


    Stay tuned for daily updates and more on (NASDAQ: NTEC)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (NASDAQ: NTEC)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NTEC is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of NTEC and does not buy, sell, or trade any shares of NTEC. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/